Zum Hauptinhalt springen

Buprenorphin

19. April 2024 | Buprenorphin

Micro-dosing with buprenorphine when switching from full agonists (methadone, SR-morphine) to buprenorphine treatment in opioid agonist-assisted treatment programmes in Slovenia

Micro-dosing with buprenorphine when switching from full agonists (methadone, SR-morphine) to buprenorphine treatment in opioid agonist-assisted treatment programmes in Slovenia Miha Lavre, and Andrej Kastelic Heroin Addiction and Related Clinical…

06. April 2024 | Buprenorphin

Case report: Successful induction of buprenorphine in medically complex patients concurrently on opioids: a case series at a tertiary care center.

Case report: Successful induction of buprenorphine in medically complex patients concurrently on opioids: a case series at a tertiary care center. Shelton T, Nama S, Hall O, Williams M. Front Pharmacol. 2024 Mar 8;15:1335345. doi: 10.3…

06. April 2024 | Buprenorphin

96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.

96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial. Farrell M, Shahbazi J, Chambers M, Byrne M, Gholami J, Zahra E…

06. April 2024 | Buprenorphin

Long-acting injectable depot buprenorphine from a harm reduction perspective in patients with ongoing substance use and multiple psychiatric comorbidities: a qualitative interview study.

Long-acting injectable depot buprenorphine from a harm reduction perspective in patients with ongoing substance use and multiple psychiatric comorbidities: a qualitative interview study. Johnson B, Monwell B, Capusan AJ. Harm Reduct J…

06. April 2024 | Buprenorphin

Protocol for harmonization of randomized trials testing the addition of behavioral therapy to buprenorphine for opioid use disorder.

Protocol for harmonization of randomized trials testing the addition of behavioral therapy to buprenorphine for opioid use disorder. McHugh RK, Bailey AJ, Weiss RD, Fitzmaurice GM. Drug Alcohol Depend Rep. 2024 Mar 13;11:100226. doi: 1…

06. April 2024 | Buprenorphin

Buprenorphine for High-dose Tramadol Dependence: A Case Report of Successful Outpatient Treatment.

Buprenorphine for High-dose Tramadol Dependence: A Case Report of Successful Outpatient Treatment. Mukau L, Wormley K, Tomaszewski C, Ahmad B, Vohra R, Herring AA. Clin Pract Cases Emerg Med. 2024 Feb;8(1):81-82. doi: 10.5811/cpcem.491…

06. April 2024 | Buprenorphin

Therapeutic Potential of Buprenorphine in Depression: A Meta-Analysis of Current Evidence.

Therapeutic Potential of Buprenorphine in Depression: A Meta-Analysis of Current Evidence. Bhivandkar S, Sarfraz Z, Jain L, Bachu A, Malo PK, Hsu M, Ayub S, Poudel L, Kumar H, Loh H, Tazin F, Ahmed S, Suzuki J. J Clin Med Res. 2024 Mar…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten